Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 1/20 | 0.53 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.53 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.53 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2015722 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL2854830 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7006048 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3852448 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL5530871 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6930290 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL351779 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3116423 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL18221941 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL871399 | 1.00 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1512 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034050-A1 | COMPOSITIONS AND USES OF ALPHA-ADRENERGIC AGENTS | LEVATION PHARMA LTD (US) | 2026-02-05 | — | — | US | claimed |
| EP-4659014-A1 | EMULSION-BASED THICK-FILM ANTIFOULING COATING FOR HIGHLY SENSITIVE ELECTROCHEMICAL SENSING | President And Fellows Of Harvard College (US) | 2025-12-10 | — | — | EP | claimed |
| US-12357561-B2 | Compositions and uses of alpha-adrenergic agents | Levation Pharma Ltd. (US) | 2025-07-15 | — | — | US | claimed |
| CN-119507021-A | Device and method for preparing rare earth ion doped nanocrystals by femtosecond laser ablation | 上海电机学院 | 2025-02-25 | — | — | CN | claimed |
| US-20240263026-A1 | CLEANING LIQUID | SAKATA INX CORP. (JP) | 2024-08-08 | — | — | US | claimed |
| WO-2024124117-A1 | EMULSION-BASED THICK-FILM ANTIFOULING COATING FOR HIGHLY SENSITIVE ELECTROCHEMICAL SENSING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-06-13 | — | — | WO | claimed |
| US-20240182738-A1 | INK SET | SAKATA INX CORPORATION (JP) | 2024-06-06 | — | — | US | claimed |
| WO-2024107917-A1 | SYNTHETIC ENAMEL AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2024-05-23 | — | — | WO | claimed |
| WO-2024078283-A1 | CRISABOROLE OR PHARMACEUTICALLY ACCEPTABLE SALT AQUEOUS SOLUTION COMPOSITION THEREOF | 海南普利制药股份有限公司 | 2024-04-18 | — | — | WO | claimed |
| EP-4349604-A1 | CLEANING LIQUID | Sakata INX Corp. (JP) | 2024-04-10 | — | — | EP | claimed |
| EP-1014809-B1 | AQUEOUS PRESERVATIVE AGENTS | NORSK HYDRO AS (NO) | 2001-11-28 | — | — | EP | claimed |
| US-20010024667-A1 | Cheese ripening process | DUPONT NUTRITION BIOSCIENCES APS (DK) | 2001-09-27 | — | — | US | claimed |
| WO-2001047366-A1 | CHEESE RIPENING PROCESS | RHODIA TEXEL LIMITED (GB) | 2001-07-05 | — | — | WO | claimed |
| EP-1091652-A1 | CHEESE RIPENING PROCESS | IMPERIAL BIOTECHNOLOGY LIMITED (GB) | 2001-04-18 | — | — | EP | claimed |
| EP-1043020-A1 | MEDICINAL COMPOSITION FOR PERCUTANEOUS ADMINISTRATION | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2000-10-11 | — | — | EP | claimed |
| EP-1014809-A1 | AQUEOUS PRESERVATIVE AGENTS | NORSK HYDRO ASA (NO) | 2000-07-05 | — | — | EP | claimed |
| WO-2000000037-A1 | CHEESE RIPENING PROCESS | IMPERIAL BIOTECHNOLOGY LIMITED (GB) | 2000-01-06 | — | — | WO | claimed |
| WO-1999012435-A1 | AQUEOUS PRESERVATIVE AGENTS | NORSK HYDRO ASA (NO) | 1999-03-18 | — | — | WO | claimed |
| US-5480574-A | 2-aminocarboxylic acid hydrochloride compositions for removal of hard-water deposits | SINGERMAN GARY M (US) | 1996-01-02 | — | — | US | claimed |
| EP-0155737-A2 | Low irritating shampoo compositions | SHIONOGI & CO., LTD. (JP) | 1985-09-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034050-A1 | COMPOSITIONS AND USES OF ALPHA-ADRENERGIC AGENTS | ADRB2, ADRA1D, ADRB1 | GPR84 926/4885FFAR1 863/4885MAPT 2678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.